Skip to content

Clinical trials

Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Clear all

3,143 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
200115
200223
200331
200431
200541
200661
200764
200865
200970
201093
201194
2012107
2013124
2014127
2015121
2016117
2017140
2018177
2019196
2020179
2021233
2022171
2023220
2024199
2025193
2026202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,743
Unknown status445
Recruiting347
Terminated191
Not yet recruiting151
Active, not recruiting129
Withdrawn76
Enrolling by invitation44
Suspended12
No longer available3
Temporarily not available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen116
Novartis Pharmaceuticals74
Bayer37
Merck KGaA, Darmstadt, Germany36
Hasselt University34
Kessler Foundation30
National Institute of Neurological Disorders and Stroke (NINDS)30
Fondazione Don Carlo Gnocchi ETS29
University of Washington28
Gazi University27

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis3,143
Multiple Sclerosis, Relapsing-Remitting301
Fatigue194
Multiple Sclerosis, Chronic Progressive135
Stroke105
Parkinson Disease97
Muscle Spasticity75
Cognitive Dysfunction69
Spinal Cord Injuries69
Autoimmune Diseases63

Trials

Showing 51 to 75 of 3,143. Each trial links to its page on Pharma Observatory.

3,043 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.